查詢結果分析
相關文獻
- 睪丸癌血液腫瘤標記的臨床意義
- 臨床第二期睪丸非精原細胞癌的治療
- 睪丸生殖細胞癌
- Second-Trimester Maternal Serum Levels of Alpha-Fetoprotein, Free β-Subunit of Human Chorionic Gonadotropin and CA-125 in Twin Pregnancy after Multifetal Pregnancy Reduction
- The Experience of Combination of Chemotherapy and Surgery in Treatment of Advanced Nonseminomatous Germ Cell Tumor of the Testis
- Maternal Urine Alpha-fetoprotein Concentrations between 14 and 21 Weeks of Gestation
- 血清腫瘤標記的篩檢、判讀與應用
- 腫瘤標記CA19-9之文獻回顧
- 癌症研究新鋒叢談(6)--以致癌基因產物作為腫瘤標記的潛力
- 前列腺癌腫瘤標記(PSA)最新應用及發展
頁籤選單縮合
題名 | 睪丸癌血液腫瘤標記的臨床意義= |
---|---|
作者 | 郭俊逸; |
期刊 | 臨床醫學 |
出版日期 | 20130900 |
卷期 | 72:3=429 2013.09[民102.09] |
頁次 | 頁214-219 |
分類號 | 416.275 |
語文 | chi |
關鍵詞 | 睪丸癌; 生殖細胞癌; 腫瘤標記; 甲型胎兒蛋白; 乙型人類絨毛膜激素; Germ cell tumor; Tumor marker; α-fetoprotein; AFP; β-human chorionic gonadotropin; β-HCG; |